China’s CanSino is seeking more vaccine contracts after the AstraZenca deal
Written by Brenda Goh and Myung KimSHANGHAI (Reuters) - The chief executive of China's CanSino Biologics, which recently announced a contract manufacturing deal to support…
Read More...
Read More...